Patents by Inventor Yuefan Zhang
Yuefan Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12049536Abstract: This disclosure generally provides tris (hydroxymethyl) phosphine oxide based polyfunctional polyester polyol compounds and resin compositions made therefrom which have improved flammability, wherein the resin composition comprising: (a) a polyfunctional isocyanate; (b) an isocyanate reactive composition comprising (b1) a polyfunctional polyol composition and a catalyst composition; and optionally (b2) a polyfunctional amine; wherein the polyfunctional polyol composition comprises tris (hydroxymethyl) phosphine oxide based polyfunctional polyester polyol compound.Type: GrantFiled: September 2, 2020Date of Patent: July 30, 2024Assignee: HUNTSMAN INTERNATIONAL LLCInventors: Zhenghe Zhang, Fan Xie, Hualiang Zhong, Yuefan Zhang
-
Patent number: 12024609Abstract: This disclosure generally provides compositions with improved flammability resistance and processes for preparing these compositions, wherein the resin composition comprising: (a) a polyfunctional isocyanate; (b) an isocyanate reactive composition comprising (b1) a polyfunctional polyol and a catalyst composition; and/or (b2) a polyfunctional amine; and (c) a benzoxazine component solved in the resin composition.Type: GrantFiled: November 9, 2018Date of Patent: July 2, 2024Assignee: Huntsman International LLCInventors: Yuefan Zhang, Fan Xie
-
Patent number: 12006412Abstract: Disclosed is a reaction mixture for the manufacturing of a polyurethane foam, which mixture can be obtained by reacting a polyfunctional isocyanate with an isocyanate-reactive compound, in the presence of a scavenger and at least one catalyst; and curing such reaction mixture enables providing a foam with reduced aldehyde emissions particularly useful in means of transport, such as interior part of cars.Type: GrantFiled: December 21, 2018Date of Patent: June 11, 2024Assignee: HUNTSMAN INTERNATIONAL LLCInventors: Bao Luan, Zuxia Rong, Yuefan Zhang, Lies Bonami, Joris Bosman
-
Publication number: 20240184704Abstract: A method and an apparatus for reading cache data, and a storage medium are provided. The method includes: receiving a read instruction; converting at least one type of address offset position corresponding to the read instruction into a coupled address offset position according to a preset rule; performing a matching operation in a data group according to the coupled address offset position which corresponds to the at least one type of address offset position and obtaining corresponding cache data; reading the cache data obtained through matching. This method is able to simultaneously perform matching operations and reading operations for at least two combined address offset positions, thereby greatly improving data reading efficiency and doubling cache data reading throughput without significantly increasing hardware logic. Furthermore, this configuration is applicable to read-only cache, read-write cache, and write-only cache, possessing great versatility.Type: ApplicationFiled: November 30, 2023Publication date: June 6, 2024Inventors: Huaisheng ZHANG, Zhongyu TAO, Yuefan ZHANG
-
Patent number: 11555091Abstract: This invention generally provides composition for making a polyurethane foam with reduced aldehyde emission and more specially to composition useful in means of transport such as interior part of cars, wherein composition is comprising: (a) a polyfunctional isocyanate; (b) an isocyanate reactive composition; and (c) a compound of the formula (I) or (II), wherein the compound (c) is present by weight percentage in the composition in an amount ranging from about 0.001 to about 10, preferably from about 0.01 to about 5, and more preferably from about 0.05 to about 2 based on the total weight of the composition. The compositions can reduce aldehyde emission, especially acetaldehyde emission in the PU foam and has no obvious influence on the mechanic properties of the foam.Type: GrantFiled: December 13, 2018Date of Patent: January 17, 2023Assignee: Huntsman International LLCInventors: Pengfei Wu, Lies Bonami, Yuefan Zhang, Joris Karel Peter Bosman, Xuerong Zhu, Ingrid Welvaert
-
Publication number: 20220356294Abstract: This disclosure generally provides tris (hydroxymethyl) phosphine oxide based polyfunctional polyester polyol compounds and resin compositions made therefrom which have improved flammability, wherein the resin composition comprising: (a) a polyfunctional isocyanate; (b) an isocyanate reactive composition comprising (b1) a polyfunctional polyol composition and a catalyst composition; and optionally (b2) a polyfunctional amine; wherein the polyfunctional polyol composition comprises tris (hydroxymethyl) phosphine oxide based polyfunctional polyester polyol compound.Type: ApplicationFiled: September 2, 2020Publication date: November 10, 2022Inventors: Zhenghe Zhang, Fan Xie, Hualiang Zhong, Yuefan Zhang
-
Publication number: 20220081526Abstract: Disclosed is a reaction mixture for the manufacturing of a polyurethane foam, which mixture can be obtained by reacting a polyfunctional isocyanate with an isocyanate-reactive compound, in the presence of a scavenger and at least one catalyst; and curing such reaction mixture enables providing a foam with reduced aldehyde emissions particularly useful in means of transport, such as interior part of cars.Type: ApplicationFiled: December 21, 2018Publication date: March 17, 2022Inventors: Bao Luan, Zuxia Rong, Yuefan Zhang, Lies Bonami, Joris Bosman
-
Publication number: 20210388168Abstract: This disclosure generally provides compositions with improved flammability resistance and processes for preparing these compositions, wherein the resin composition comprising: (a) a polyfunctional isocyanate; (b) an isocyanate reactive composition comprising (b1) a polyfunctional polyol and a catalyst composition; and/or (b2) a polyfunctional amine; and (c) a benzoxazine component solved in the resin composition.Type: ApplicationFiled: November 9, 2018Publication date: December 16, 2021Inventors: Yuefan Zhang, Fan Xie
-
Publication number: 20210221942Abstract: This invention generally provides composition for making a polyurethane foam with reduced aldehyde emission and more specially to composition useful in means of transport such as interior part of cars, wherein composition is comprising: (a) a polyfunctional isocyanate; (b) an isocyanate reactive composition; and (c) a compound of the formula (I) or (II), wherein the compound (c) is present by weight percentage in the composition in an amount ranging from about 0.001 to about 10, preferably from about 0.01 to about 5, and more preferably from about 0.05 to about 2 based on the total weight of the composition. The compositions can reduce aldehyde emission, especially acetaldehyde emission in the PU foam and has no obvious influence on the mechanic properties of the foam.Type: ApplicationFiled: December 13, 2018Publication date: July 22, 2021Inventors: Pengfei Wu, Lies Bonami, Yuefan Zhang, Joris Karel Peter Bosman, Xuerong Zhu, Ingrid Welvaert
-
Patent number: 10092592Abstract: The present invention belongs to the field of medicine technology, particularly relating to an application of cyclic dinucleotide (cGAMP) in tumor treatment. Researches carried out in the present invention show that, cGAMP can inhibit growth of many types of tumor cells, with remarkable anti-tumor effect, thus, it can be used in preparation of anti-tumor drugs; and the prepared anti-tumor drugs have low toxicity and favorable effect. Proved by a subcutaneous tumor model in nude mice, cGAMP has a remarkable inhibition effect on tumors of human gastric carcinoma cell line MNK-45, human lung adenocarcinoma cell line A549, human colorectal carcinoma cell line Lovo, human hepatocellular carcinoma cell line SMMC-7721, human prostatic carcinoma cell line PC-3 and human pancreatic carcinoma cell SW1990, which are subcutaneously implanted in nude mice, and also proved by animal acute toxicity experiment. cGAMP has a relatively low acute toxicity, therefore and may be used for preparing anti-tumor drugs.Type: GrantFiled: April 20, 2015Date of Patent: October 9, 2018Assignee: Fudan UniversityInventors: Xiangshi Tan, Tiejun Li, Qiming Xu, Jie Pan, Yaocheng Rui, Hao Cheng, Yuefan Zhang
-
Publication number: 20170196902Abstract: The present invention belongs to the field of medicine technology, particularly relating to an application of cyclic dinucleotide (cGAMP) in tumor treatment. Researches carried out in the present invention show that, cGAMP can inhibit growth of many types of tumor cells, with remarkable anti-tumor effect, thus, it can be used in preparation of anti-tumor drugs; and the prepared anti-tumor drugs have low toxicity and favorable effect. Proved by a subcutaneous tumor model in nude mice, cGAMP has a remarkable inhibition effect on tumors of human gastric carcinoma cell line MNK-45, human lung adenocarcinoma cell line A549, human colorectal carcinoma cell line Lovo, human hepatocellular carcinoma cell line SMMC-7721, human prostatic carcinoma cell line PC-3 and human pancreatic carcinoma cell SW1990, which are subcutaneously implanted in nude mice, and also proved by animal acute toxicity experiment. cGAMP has a relatively low acute toxicity, therefore and may be used for preparing anti-tumor drugs.Type: ApplicationFiled: April 20, 2015Publication date: July 13, 2017Applicant: FUDAN UNIVERSITYInventors: Xiangshi TAN, Tiejun LI, Qiming XU, Jie PAN, Yaocheng RUI, Hao CHENG, Yuefan ZHANG
-
Patent number: 8343921Abstract: Use of polypeptide micromolecule MLIF in preparing medicine for preventing and treating myocardial ischmia, where amino acid sequence of the polypeptide micromolecule MLIF is Met-Gln-Cys-Asn-Ser (SEQ ID NO:1).Type: GrantFiled: January 23, 2012Date of Patent: January 1, 2013Assignee: Shanghai Bajiayi Pharmaceutical Science and Technology Co. Ltd.Inventors: Yaocheng Rui, Tiejun Li, Pengyuan Yang, Yuefan Zhang
-
Publication number: 20120122786Abstract: Use of polypeptide micromolecule MLIF in preparing medicine for preventing and treating myocardial ischmia, where amino acid sequence of the polypeptide micromolecule MLIF is Met-Gln-Cys-Asn-Ser (SEQ ID NO:1).Type: ApplicationFiled: January 23, 2012Publication date: May 17, 2012Applicant: THE SECOND MILITARY MEDICAL UNIVERSITY, PLAInventors: Yaocheng Rui, Tiejun Li, Pengyuan Yang, Yuefan Zhang